News
In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...
A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data ...
Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early ...
While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...
A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 ...
9d
MedPage Today on MSNMost T1D Patients Insulin-Free After Stem Cell Infusion, Small Trial ReportsCHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
In phase 2 of the FORWARD study, 83% of participants with type 1 diabetes achieved insulin independence a year after ...
US drugmaker Vertex Pharmaceuticals has announced simultaneous presentation and publication of updated data from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results